Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Comment by DatAssBanditon Jun 11, 2018 1:58pm

155 Views

Post# 28155402

RE:RE:RE:RE:on the moveeee

newbie2018 wrote: showing me 1.3 million on RBC platform
DatAssBandit wrote:

newbie2018 wrote: loving the action. I reckon the wall at 16 cents will come down. This has been held down for so long. Back into the 20s and possibly 30s we go.

Busyzzindahouse wrote: Its goooo timeeeee

There is good volume. Hopefully you are correct. My app is showing 2.4 million shares traded so far.